JPMorgan initiates Seaport Therapeutics stock with overweight rating
Corroborated by 2 sources from 2 publishers
globalgeneral5/26/2026
TL;DR
JPMorgan initiates Seaport Therapeutics stock with overweight rating.
Corroborated by 2 sources from 2 publishers
JPMorgan initiates Seaport Therapeutics stock with overweight rating.